Initial Insulin Regimen for Managing Diabetes Mellitus
Start with basal insulin at 10 units once daily (or 0.1-0.2 units/kg/day) for most insulin-naive patients with type 2 diabetes, administered at the same time each day, and continue metformin unless contraindicated. 1, 2
Patient Assessment and Regimen Selection
Type 2 Diabetes: Basal Insulin Initiation
- For patients with HbA1c 7.5-9%: Begin with basal insulin alone (insulin glargine, detemir, or degludec) at 10 units once daily or 0.1-0.2 units/kg/day, typically at bedtime 1, 2, 3
- For patients with HbA1c ≥9-10% without severe symptoms: Start with the same basal insulin dose but anticipate more aggressive titration 2, 4
- For patients with HbA1c ≥10-12% with symptomatic hyperglycemia or catabolic features (weight loss, polyuria, polydipsia): Immediately initiate basal-bolus therapy with 0.3-0.5 units/kg/day total daily dose, split 50% basal and 50% prandial insulin divided among three meals 2, 4, 5
Type 1 Diabetes: Basal-Bolus Required from Onset
- Total daily dose: 0.4-1.0 units/kg/day, with 0.5 units/kg/day typical for metabolically stable patients 2, 6
- Distribution: Approximately 40-60% as basal insulin (glargine or detemir) once daily, and 50-60% as rapid-acting insulin (lispro, aspart, or glulisine) divided before meals 1, 2
- Timing: Rapid-acting insulin should be administered 0-15 minutes before meals 1, 5
Foundation Therapy: Continue Metformin
- Metformin must be continued at maximum tolerated dose (up to 2000-2550 mg daily) when initiating insulin therapy unless contraindicated (GFR <30 mL/min/1.73m²) 1, 2, 5
- This combination reduces total insulin requirements by approximately 30%, decreases weight gain, and lowers hypoglycemia risk compared to insulin alone 2, 5, 7
Titration Protocol for Basal Insulin
Standard Titration Algorithm
- Increase by 2 units every 3 days if fasting glucose is 140-179 mg/dL 1, 2
- Increase by 4 units every 3 days if fasting glucose is ≥180 mg/dL 1, 2
- Target fasting glucose: 80-130 mg/dL (4.4-7.2 mmol/L) 1, 2, 3
- If hypoglycemia occurs without clear cause, reduce dose by 10-20% immediately 1, 2
Patient Self-Titration
- Instruct patients in self-titration based on daily fasting glucose monitoring, which improves glycemic control compared to provider-directed titration alone 1, 2
- Patients should check fasting glucose every morning during titration and adjust according to the algorithm above 2
Critical Threshold: When to Add Prandial Insulin
Stop escalating basal insulin when the dose exceeds 0.5 units/kg/day and add prandial insulin instead. 1, 2, 3
Signs of "Overbasalization"
- Basal insulin dose >0.5 units/kg/day without achieving HbA1c goals 1, 2
- Bedtime-to-morning glucose differential ≥50 mg/dL (excessive overnight glucose drop) 2
- Hypoglycemia episodes despite elevated HbA1c 2
- High glucose variability throughout the day 2
Adding Prandial Insulin
- Start with 4 units of rapid-acting insulin before the largest meal, or use 10% of the current basal dose 1, 2
- Titrate by 1-2 units every 3 days based on 2-hour postprandial glucose readings, targeting <180 mg/dL 1, 2
- Add to additional meals sequentially if HbA1c remains above target after 3-6 months 1, 2
Special Populations and Dose Adjustments
Severe Hyperglycemia (Blood Glucose ≥300-350 mg/dL)
- Consider higher starting doses of 0.3-0.5 units/kg/day as total daily insulin, using basal-bolus regimen from the outset 2, 4, 7
- This represents approximately 20-35 units/day for a 70 kg patient, split 50% basal and 50% prandial 2
Elderly or High-Risk Patients
- Use lower starting doses of 0.1-0.25 units/kg/day for patients >65 years, those with renal impairment (GFR <45 mL/min), or poor oral intake 2
- Target less stringent HbA1c goals of 7.5-8.5% rather than <7% to minimize hypoglycemia risk 2, 8
Chronic Kidney Disease
- CKD Stage 5 with type 2 diabetes: Reduce total daily insulin dose by 50% 2, 8
- CKD Stage 5 with type 1 diabetes: Reduce total daily insulin dose by 35-40% 2, 8
Hospitalized Patients
- For insulin-naive or low-dose patients: Start with 0.3-0.5 units/kg/day total daily dose, split 50% basal and 50% bolus 2
- For patients on high-dose home insulin (≥0.6 units/kg/day): Reduce total daily dose by 20% upon admission to prevent hypoglycemia 2
Insulin Selection and Administration
Basal Insulin Options
- Insulin glargine (Lantus, Basaglar, Toujeo): Once daily, typically at bedtime 1, 6, 9
- Insulin detemir (Levemir): Once or twice daily; may require twice-daily dosing for 24-hour coverage 1, 10
- Insulin degludec (Tresiba): Once daily, offers greatest flexibility in timing 2
Rapid-Acting Insulin Options for Prandial Coverage
- Insulin lispro, aspart, or glulisine: Administer 0-15 minutes before meals 1, 5
- Regular human insulin: Administer 30-45 minutes before meals if rapid-acting analogs unavailable 2
Injection Technique
- Use 4-mm pen needles or 6-mm syringe needles as first-line choice—they are safe, effective, and less painful 5
- Rotate injection sites within the same region (thigh, abdomen, or upper arm) to prevent lipohypertrophy 1, 5
- Never mix insulin glargine with other insulins due to its acidic pH 2, 5
Monitoring Requirements
- Daily fasting glucose monitoring is essential during titration phase 1, 2
- Check HbA1c every 3 months during intensive titration, then every 3-6 months once stable 1, 2
- For patients on prandial insulin, also monitor 2-hour postprandial glucose to guide mealtime insulin adjustments 1, 2
Common Pitfalls to Avoid
Never Delay Insulin Initiation
- Delaying insulin in patients not achieving glycemic goals with oral medications prolongs hyperglycemia exposure and increases complication risk 1, 2, 8
- For HbA1c ≥9%, consider starting insulin earlier in the treatment algorithm 2, 8
Never Discontinue Metformin When Starting Insulin
- Unless contraindicated, metformin should be continued as it provides superior control with less weight gain and lower insulin requirements 1, 2, 5, 7
Never Use Sliding Scale Insulin as Monotherapy
- Sliding scale insulin alone is explicitly condemned by all major diabetes guidelines—it treats hyperglycemia reactively rather than preventing it, leading to dangerous glucose fluctuations 2, 8
- Always use scheduled basal insulin with correction doses as adjunct only 2
Never Continue Escalating Basal Insulin Beyond 0.5-1.0 Units/kg/Day
- Continuing to increase basal insulin beyond this threshold without adding prandial coverage leads to overbasalization with increased hypoglycemia risk and suboptimal control 1, 2, 3
- At this point, add prandial insulin or consider GLP-1 receptor agonist combination therapy 1, 2
Never Give Rapid-Acting Insulin at Bedtime
- This significantly increases nocturnal hypoglycemia risk 2
- Bedtime insulin should be basal insulin only 1, 2
Patient Education Essentials
- Hypoglycemia recognition and treatment: Treat any glucose <70 mg/dL immediately with 15 grams of fast-acting carbohydrate 1, 2
- Injection technique and site rotation to prevent lipohypertrophy 1, 5
- Self-monitoring of blood glucose with clear targets and action plans 1, 2
- Sick day management rules and when to contact healthcare provider 2
- Insulin storage and handling to maintain potency 2